Mild hyperphenylalaninemia: To treat or not to treat

Journal of Inherited Metabolic Disease

Volumn 34, Issue 3, 2011, Pages 651-656

  Van Spronsen, Francjan J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

AMINO ACID BLOOD LEVEL; BRAIN DEVELOPMENT; CHILD CARE; DEVELOPMENTAL DISORDER; DIET THERAPY; DISEASE SEVERITY; FUNCTIONAL DISEASE; HUMAN; HYPERPHENYLALANINEMIA; INTELLECTUAL IMPAIRMENT; INTELLIGENCE QUOTIENT; MEDICAL DECISION MAKING; MENTAL PERFORMANCE; NEUROPHYSIOLOGY; NEUROPSYCHOLOGY; PATIENT MONITORING; PHENYLKETONURIA; PROTEIN INTAKE; REVIEW;

CHOICE BEHAVIOR; DECISION MAKING; HUMANS; OSMOLAR CONCENTRATION; PHENYLALANINE; PHENYLKETONURIAS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 79959782071     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9283-y     Document Type: Review

References (50)

1. Acosta PB, Yannicelli S, Marriage B (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287-291 (Pubitemid 28430857)
2. Anastasoaie V, Kurzius L, Forbes P, Waisbren S (2008) Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Mol Genet Metab 95:17-20
3. Arnold GL, Kramer BM, Kirby RS et al (1998) Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria. Acta Paediatr 87:565-570 (Pubitemid 28257299)
4. Azen CG, Koch R, Friedman EG et al (1991) Intellectual development in 12-year-old children treated for phenylketonuria. Am J Dis Child 145:35-39
5. Berry HK, O'Grady DJ, Perlmutter LJ, Bofinger MK (1979) Intellectual development and academic achievement of children treated early for phenylketonuria. Dev Med Child Neurol 21:311-320 (Pubitemid 10223511)
6. Blau N, van Spronsen FJ, Levy HL (2010a). Phenylketonuria. Lancet, accepted
7. Blau N, Belanger-Quintana A, Demirkol M et al (2010b) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99:109-115
8. Burgard P, Rey F, Rupp A, Abadie V, Rey J (1997) Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatr Res 41:368-374 (Pubitemid 27097904)
9. Cabalska B, Duczyńska N, Borzymowska J, Zorska K, Koślacz-Folga A, Bozkowa K (1977) Termination of dietary treatment in phenylketonuria. Eur J Pediatr 126:253-262 (Pubitemid 8215283)
10. Costello PM, Beasley MG, Tillotson SL, Smith I (1994) Intelligence in mild atypical phenylketonuria. Eur J Pediatr 153:260-263 (Pubitemid 24101349)
11. Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 62(i-v):1-208
12. Dobbelaere D, Michaud L, Debrabander A et al (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J Inherit Metab Dis 26:1-11 (Pubitemid 36817933)
13. Gassió R, Artuch R, Vilaseca MA et al (2005) Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population. Dev Med Child Neurol 47:443-448 (Pubitemid 40895408)
14. Griffiths P, Paterson L, Harvie A (1995) Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria. J Intellect Disabil Res 39:365-372
15. Guldberg P, Rey F, Zschocke J et al (1998) A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am J Hum Genet 63:71-79 (Pubitemid 30428320)
16. Güttler F (1980) Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Acta Paediatr Scand Suppl 280:1-80
17. Hanley WB, Feigenbaum A, Clarke JT, Schoonheyt W, Austin V (1993) Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Lancet 342:997 (Pubitemid 23305527)
18. Hendrikx MM, van der Schot LW, Slijper FM, Huisman J, Kalverboer AF (1994) Phenylketonuria and some aspects of emotional development. Eur J Pediatr 153:832-835 (Pubitemid 24314756)
19. Hoeksma M, Van Rijn M, Verkerk PH, et al. (2005) The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J Inherit Metab Dis 28(6):845-54. (Pubitemid 43168920)
20. Holtzman NA, Kronmal RA, van Doorninck W, Azen C, Koch R (1986) Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. N Engl J Med 314:593-598 (Pubitemid 16132722)
21. Huemer M, Födinger M, Bodamer OA et al (2008) Total homocysteine, B-vitamins and genetic polymorphisms in patients with classical phenylketonuria. Mol Genet Metab 94:46-51
22. Huijbregts SC, de Sonneville LM, Licht R, van Spronsen FJ, Verkerk PH, Sergeant JA (2002) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40:7-15 (Pubitemid 32929971)
23. Huijbregts SC, de Sonneville LM, Van Spronsen FJ et al (2003) Motor function under lower and higher controlled processing demands in early and continuously treated phenylketonuria. Neuropsychology 17:369-379 (Pubitemid 37013148)
24. Hvas AM, Nexo E, Nielsen JB (2006) Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU). J Inherit Metab Dis 29:47-53
25. Koch R, Trefz F, Waisbren S (2010) Psychosocial issues and outcomes in maternal PKU. Mol Genet Metab 99(Suppl 1):S68-S74
26. Lang MJ, Koch R, Fishler K, Baker R (1989) Nonphenylketonuric hyperphenylalaninemia. Am J Dis Child 143:1464-1466 (Pubitemid 20011595)
27. Levy HL, Shih VE, Karolkewicz V et al (1971) Persistent mild hyperphenylalaninemia in the untreated state. A prospective study. N Engl J Med 285:424-429
28. Luciana M, Sullivan J, Nelson CA (2001) Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria. Child Dev 72:1637-1652 (Pubitemid 33602780)
29. Medical Research Council for Phenylketonuria (1993) Recommendations on the dietary management of phenylketonuria. Report of medical research council working party on phenylketonuria. Arch Dis Child 68:426-427
30. Modan-Moses D, Vered I, Schwartz G et al (2007) Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis 30:202-208 (Pubitemid 46488002)
31. Pietz J, Fätkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H (1997) Psychiatric disorders in adult patients with early-treated phenylketonuria. Pediatrics 99:345-350 (Pubitemid 27176002)
32. Ris MD, Williams SE, Hunt MM, Berry HK, Leslie N (1994) Earlytreated phenylketonuria: adult neuropsychologic outcome. J Pediatr 124:388-392 (Pubitemid 24094448)
33. Schaefer F, Burgard P, Bazler U et al (1994) Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr 83:534-541 (Pubitemid 24184264)
34. Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn., pp 495-546
35. Sharman R, Sullivan K, Young R, McGill J (2010) A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels. Dev Neuropsychol 35:57-65
36. Simon E, Schwarz M, Roos J et al (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 26:25
37. Smith I, Beasley MG, Wolff OH, Ades AE (1988) Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr 112:403-408 (Pubitemid 18079823)
38. Smith ML, Saltzman J, Klim P, Hanley WB, Feigenbaum A, Clarke JT (2000) Neuropsychological function in mild hyperphenylalaninemia. Am J Ment Retard 105:69-80 (Pubitemid 30413394)
39. van Spronsen FJ, Ahring KK, Gizewska M (2009) PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders. J Inherit Metab Dis 32:58-64
40. van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the need for a new guideline. J Inherit Metab Dis 31:673-679
41. Van Spronsen FJ, Enns GM (2010) Future treatment strategies in phenylketonuria. Mol Genet Metab Suppl 99:90-95
42. van Spronsen FJ, van Rijn M, van Dijk T et al (1993) Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting/ postprandial) in patients with phenylketonuria: effect of sample timing. Pediatrics 92:570-573
43. van Spronsen FJ, van Dijk T, Smit GP, van Rijn M, Reijngoud DJ, Berger R, Heymans HS (1996) Phenylketonuria: plasma phenylalanine responses to different distributions of the daily phenylalanine allowance over the day. Pediatrics 97:839-844 (Pubitemid 26170944)
44. Verkerk PH, van Spronsen FJ, Smit GP, Sengers RC (1994) Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee. Arch Dis Child 71:114-118 (Pubitemid 24261112)
45. Waisbren SE, Levy HL (1991) Agoraphobia in phenylketonuria. J Inherit Metab Dis 14:755-764
46. Weglage J, Fünders B, Wilken B et al (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151:522-525
47. Weglage J, Ullrich K, Pietsch M, Fünders B, Zass R, Koch HG (1996a) Untreated non-phenylketonuric-hyperphenylalaninaemia: intellectual and neurological outcome. Eur J Pediatr 155(Suppl 1):S26-S28 (Pubitemid 126721387)
48. Weglage J, Schmidt E, Fünders B, Pietsch M, Ullrich K (1996b) Sustained attention in untreated non-PKU-hyperphenylalaninemia. J Clin Exp Neuropsychol 18:343-348 (Pubitemid 26297745)
49. Weglage J, Pietsch M, Feldmann R et al (2001) Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia. Pediatr Res 49:532-536 (Pubitemid 32274967)
50. Zeman J, Bayer M, Stepán J (1999) Bone mineral density in patients with phenylketonuria. Acta Paediatr 88:1348-1351 (Pubitemid 30012556)